OMEICOS Therapeutics is a clinical-stage biopharmaceutical company focused on developing a novel class of synthetic bioactive lipid mediators for the treatment of cardiovascular, ophthalmic and other chronic inflammatory diseases
OMEICOS Therapeutics is a clinical-stage biopharmaceutical company focused on developing a novel class of synthetic bioactive lipid mediators for the treatment of cardiovascular, ophthalmic and other chronic inflammatory diseases.